CancerNetwork Members: Login | Register
Become a fan on  Facebook  Add us on  Google Plus Follow us on  Twitter Join us on LinkedIn Sign up for our Newsletters Subscribe to our RSS Feed

 

CancerNetwork SearchMedica Medline Drugs

Powered by SearchMedica

 
PUBLICATIONS
NEWS
PODCASTS
TOPICS
BLOGS
NURSES
PATIENTS
JOBS
CONFERENCES
CME
SUPPLEMENTS
 

Home »

ONCOLOGY Nurse Edition. Vol. 22 No. 4
Pages: 1  2  
Next
 

Menopausal Symptoms Following Tamoxifen Treatment for Breast Cancer

By Debra L. Barton, RN, PhD, AOCN
Mayo Clinic Cancer Center
Rochester, Minnesota

| April 1, 2008
Debra L. Barton is Associate Professor of Oncology, Department of Medicine, Mayo Clinic Cancer Center.
Hot flashes negatively impacted the patient’s mood, stress level, sleep, and relationship with her husband. Breathing exercises and pharmacological management with a low-dose antidepressant alleviated the problem.

The patient, DB, is a 47-year-old woman who has been married 24 years. Her daughter is away at college and her son is a high school senior. Last summer, DB was diagnosed with invasive ductal carcinoma of the breast. She had one positive lymph node with an estrogen receptor/progesterone receptor strongly positive tumor.

DB underwent a mastectomy followed by chemotherapy with Adriamycin (doxorubicin)/Cytoxan (cyclophosphamide), and Taxol (paclitaxel). She completed her chemotherapy at the end of October and began treatment with tamoxifen(Drug information on tamoxifen) almost immediately. Her last menstrual period was last August, about midway through chemotherapy.

In February, DB presents to the Women’s Health Clinic for management of her hot flashes, which have caused her extreme distress and serious sleep disruption during the past 3 months. On a general numeric analogue scale ranging from 0 (no problem) to 10 (worst problem ever), she rates her level of fatigue at an 8 out of 10, trouble sleeping at 9 out of 10, distress at 7 out of 10, and negative mood at 9 out of 10.

DB states that she experiences about six hot flashes daily (mostly of moderate intensity), with at least three to four severe ones occurring at night. As a result, DB has moved into her daughter’s bedroom in the basement, as she was disturbing both her son’s and husband’s sleep. DB is considering looking for another job in order to change her work hours to evenings, because she seems to be able to sleep without hot flashes during the early morning hours. She is concerned, however, that doing so would give her even less time to spend with her family.

Nursing Management

The nurse appropriately evaluated the scope of effects that hot flashes were having on DB: negative mood; distress; and impact on sleep, work, and her relationship with her husband. Nursing management included educating the patient about keeping a diary for at least the first 2 weeks, so that she could better understand triggers for her hot flashes and be able to accurately evaluate her reduction in hot flashes post treatment.

The nurse also educated DB about what side effects to monitor: nausea, decreased appetite, dry mouth, and sexual function changes, particularly changes in her experience of orgasm.[1,4]

Outcome

By the end of the first week of treatment, DB experienced a 35% reduction in her hot flashes and was sleeping through much of the night, only awakening once or twice. However, she was experiencing moderate to severe nausea and contacted the nurse.

After assessment revealed that DB was taking her venlafaxine with coffee and a piece of fruit in the morning, she was advised by the nurse to take the drug with a full meal, such as a bowl of cereal or a sandwich. DB then began taking the medication immediately after eating lunch; by the third week following this change in her pill-taking routine, her nausea was very tolerable.

She began to practice the breathing/relaxation exercises when she first got up in the morning and before bed. By the end of the second week of treatment, her hot flashes had decreased an additional 25%, for a total reduction of 60% (to about four to five mild episodes). Both her fatigue and distress levels improved—she now rated both at 4 out of 10—and her negative mood was gone.

DB moved back into her bedroom with her husband. As instructed, she titrated down to 37.5 mg/day of venlafaxine during her fifth week of hot flash treatment, still practicing breathing at least once per day, and her hot flashes did not increase.

Pages: 1  2  
Next
 

Join the Conversation

Want to join the conversation? If you're a healthcare professional, we'd like to hear your comments. Just sign in or register today to become part of our growing, online community.

Treatment Summary
The advance practice nurse gave DB a prescription for Effexor XR (venlafaxine hydrochloride) 37.5 mg daily for 1 week, titrating up to 75 mg daily thereafter.[1] She referred DB to a nurse colleague who taught her to do slow, deep breathing and relaxation for further management of hot flashes.[2,3] Follow-up instructions were that when DB felt competent at performing those breathing/relaxation exercises daily, and if she were satisfied with the decrease in incidence of her hot flashes, she could titrate down to 37.5 mg/day and continue the breathing and relaxation exercises.

Practice Pearls

• When a patient's hot flashes are dramatically impacting sleep or disrupting daily activities, pharmacological intervention is needed.
• The strongest evidence for pharmacological management of hot flashes is with gabapentin, venlafaxine, and paroxetine.
• Data on use of breathing and relaxation techniques alone suggest that they yield up to a 30% reduction in hot flashes.






 
TOPIC INDEX

Cancer Types

 
  • Breast
  • Breast (HER2+)
  • Breast (Triple-Negative)
  • CML
  • Colorectal
  • Gastrointestinal
  • GIST
  • Genitourinary
  • Gynecologic
  • Head & Neck
  • Hematology
  • Kidney (Renal Cell)
  • Leukemia
  • Lung
  • Lymphoma
  • Melanoma
  • Multiple Myeloma
  • Ovarian
  • Prostate
  • Sarcoma

Supportive Care

More Topics

  • Bone Metastases
  • End-of-Life Care
  • Palliative Care
  • Ethics in Oncology
  • Practice Management
  • Practice & Policy


All Topics 


 
IMAGE IQ

Lower Back Pain in an Elderly Man With a History of Localized Prostate Cancer
James B. Yu, MD1 , May 17, 2013

A 70-year-old man with a history of localized prostate cancer treated with whole-pelvis radiation therapy with a boost to the prostate, in conjunction with androgen deprivation therapy 7 years prior, presented with lower back pain. A bone scan revealed an area of activity in the sacrum. What is the most likely diagnosis?

More Image IQs 

 
FROM PHYSICIANS PRACTICE
Primary Care Can't Thrive Without Nurse Practitioners
Courtney H. Lyder, ND,  May 17, 2013
With a projected shortfall of primary-care physicians, it's time for alternate solutions to patient care. Nurse practitioners are one logical remedy.
VWhat Physicians Can Learn from the Allscripts EHR Lawsuit
Marisa Torrieri,  May 16, 2013
Lawsuit prompts question: What should physicians do to ensure they end up with a great EHR instead of buyer’s remorse?
Eight Ways ICD-9 Will Still Matter to Medical Practices
Brenda Edwards, CPC,  May 15, 2013
What should your medical practice do with your ICD-9-CM book after October 1, 2014? Keep it.
Seven Ways Technology Can Speed Up Patient Collections
Cheyenne Brinson,  May 15, 2013
Failing to adopt widely available billing and collections technology can cost medical practices big. Here's how to do it right.
Four Reasons Private Medical Practice is Becoming Extinct
Carol Stryker,  May 15, 2013
It’s becoming increasingly difficult for private medical practices to thrive. Here’s what’s driving the trend toward consolidation.
 

 

 
MOST POPULAR
  • Most Popular
  • Most Emailed
  • Most Recent
  • Skin Lesions
  • Colorectal Lesions
  • “This Is My Last Day on Earth”
  • Dermatologic Adverse Events Associated With Targeted Therapies
  • Slide Show: Squamous Cell Carcinoma of the Head and Neck
  • “This Is My Last Day on Earth”
  • Dermatologic Adverse Events Associated With Targeted Therapies
  • Recurrent Epithelial Ovarian Cancer: An Update on Treatment
  • ONS: Understanding Spirituality and How It Can Be Used to Help Patients
  • Colorectal Lesions
  • New AUA Guidelines for Prostate Cancer Screening
  • 50 Shades of Pink—And Why It Helps to Know the Difference
  • Genomics Studies Identify Testicular Cancer Risk Variants
  • Lower Back Pain in an Elderly Man With a History of Localized Prostate Cancer
  • FDA Approves Erlotinib (Tarceva) as First-Line Lung Cancer Therapy for Certain Patients
Click here to subscribe to our newsletter
 
COMMENTS
  • Most Commented
  • Most Recent
  • “This Is My Last Day on Earth”
  • Financial Toxicity, Part II: How Can We Help With the Burden of Treatment-Related Costs?
  • Patient Quality of Life Endpoints in Oncology Trials, Part II
  • Who's Coding Whom?
  • “How Do I Say This Nicely? Your Oncologist Wasn't Following Guidelines”
  • Study: Cholesterol Drugs Reduced Risk of Prostate Cancer Death
  • “This Is My Last Day on Earth”
  • ONS: Safe Handling of Chemotherapy
  • Financial Toxicity, Part II: How Can We Help With the Burden of Treatment-Related Costs?
  • Conflicts of Interest in Medicine: What About Ties to Payers?
Click here to subscribe to our newsletter



CancerNetwork on Facebook

CancerNetwork | ConsultantLive | Diagnostic Imaging | Musculoskeletal Network | OBGYN.net | PediatricsConsultantLive |
Physicians Practice | Psychiatric Times | SearchMedica | Medical Resources

© 1996 - 2013 UBM Medica LLC, a UBM company
Privacy Statement - Terms of Service - Advertising Information - Editorial Policy Statement - UBM Medica Network Privacy Policy